rs876658650
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4_SupportingPP5
The NM_000179.3(MSH6):c.3732_3734delATT(p.Leu1244del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000179.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:2
The c.3732_3734delATT variant (also known as p.L1244del) is located in coding exon 8 of the MSH6 gene. This variant results from an in-frame ATT deletion between nucleotide positions 3732 and 3734 and a deletion of the leucine at codon 1244. This alteration has been identified in multiple families who meet Amsterdam Criteria for Lynch Syndrome and it segregates with disease in these families (Ambry internal data). Based on internal structural assessment, this alteration disrupts the structure of the ATPase domain (Warren JJ et al. Mol. Cell. 2007 May;26:579-92; Ambry internal data). This amino acid position is highly conserved in available vertebrate species. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
This variant causes an in-frame deletion of one amino acid located in the ATPase domain of the MSH6 protein. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in multiple individuals affected with Lynch syndrome (ClinVar SCV000750673.6, SCV000275689.6). It has been shown that this variant segregates with disease (communication with an external laboratory; ClinVar SCV000275689.6). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. -
not provided Pathogenic:1Uncertain:1
In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 17531815, 21120944) -
The MSH6 c.3732_3734delATT; p.Leu1244del variant (rs876658650), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 231746). However, a nearby in-frame deletion, p.Arg1242del has been reported in individuals with colon cancer and has been classified likely pathogenic by the InSIGHT expert panel (Thompson 2014). The c.3732_3734delATT variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant deletes a single leucine residue leaving the rest of the protein in-frame. Due to limited information, the clinical significance of the c.3732_3734delATT; p.Leu1244de variant is uncertain at this time. -
Hereditary nonpolyposis colon cancer Pathogenic:1
Variant summary: MSH6 c.3732_3734delATT (p.Leu1244del) results in an in-frame deletion that is predicted to remove one amino acid from the ATPase domain of the encoded protein. The variant was absent in 251206 control chromosomes. c.3732_3734delATT has been observed in individuals with a personal and family history of Lynch Syndrome/Hereditary Nonpolyposis Colorectal Cancer (personal correspondence, partner laboratory). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 231746). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Lynch syndrome Pathogenic:1
This variant has been reported in multiple individuals with Lynch Syndrome (Ambry, Invitae internal data listed in ClinVar). This variant is located in a well-established functional domain of the protein where other pathogenic or likely pathogenic variants have been described. (PMID: 17531815) This variant is absent from or rare in large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant has been reported to co-segregate with disease in more than one family (Ambry, Invitae internal data). -
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
This variant, c.3732_3734del, results in the deletion of 1 amino acid(s) of the MSH6 protein (p.Leu1244del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with Lynch syndrome-related cancers (external communication, internal data). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 231746). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at